Chiron Corporation
Chiron Corporation (NASDAQ: CHIR (http://quotes.nasdaq.com/asp/SummaryQuote.asp?symbol=CHIR&selected=CHIR)) is a pharmaceutical company based in Oxford. In 2004, it got high media coverage after the UK government suspended its licence for manufacuring Fluvirin, an influenza virus vaccine, leaving the United States government short of the vaccine. It later emerged that the FDA may have been aware of the problem nine months earlier, but a miscommunication between the company and the FDA left the problem unsolved until MHPRA (Medicines and Healthcare Products Regulatory Agency), the British equivalent of the FDA stepped in and suspended Chiron's licence[1] (http://www.washingtonpost.com/wp-dyn/articles/A58482-2004Nov17.html). The company has been in operation since 1981.
Chiron products:
- Agrippal
- Begrivac
- Fluad
- Fluvirin
See also
- Medicines and Healthcare products Regulatory Agency
- British Medical Association
- Food and Drug Administration
External links
- UK government suspend Chiron licence (http://news.bbc.co.uk/1/hi/health/3717726.stm)
- FDA may have covered up for Chiron (http://www.washingtonpost.com/wp-dyn/articles/A58482-2004Nov17.html)